Board logo

subject: Germany In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 [print this page]


Germany In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Germany In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Germany

Scope

- The report provides information on the German in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.

- Total revenues, end users

- Market shares of all the key competitors.

- Key pipeline products that are set to shape the market, broken down by sector.

- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.

- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.

- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

- Key mergers and acquisitions, partnerships, private equity investments and IPOs.

- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the in vitro diagnostics devices market in Germany.

- Evaluate and compare the attractiveness of the market in the country.

- Identify growth segments and opportunities in each industry sector within the country.

- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.

- Analyze the competitiveness of the market in the country and identify hotspots.

- Develop strategies based on the latest product, brand, expansion and research and development news in the country.

- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.

- Identify and analyze the strengths and weaknesses of the industry incumbents in the country. Ventana Medical Systems, Inc.

Sysmex Corporation

Siemens Healthcare

Qiagen N.V.

Phadia AB

Ortho-Clinical Diagnostics Inc.

OLYMPUS CORPORATION

Inverness Medical Innovations, Inc.

Hologic, Inc.

Gen-Probe Incorporated

F. Hoffmann-La Roche Ltd.

DiaSorin S.p.A

Dade Behring Holdings, Inc.

Bio-Rad Laboratories, Inc.

bioMerieux S.A.

Becton, Dickinson and Company

Beckman Coulter, Inc.

Abbott Laboratories

AdnaGen AG

AMODIA Bioservice GmbH

SIRS-Lab GmbH

ACGT ProGenomics AG

AnDiaTec GmbH & Co. KG

BioRepair GmbH

Biotest AG

Scienion AG

Invitek Biotechnolgy & Biodesign Ltd.

ScheBo Biotech AG

Serion Immundiagnostica GmbH

Viramed Biotech AG

MEDIPAN GmbH

Epigenomics AG

SARSTEDT AG & Co.

BioCat GmbH

8sens.biognostic GmbH For more information, please visit : http://www.aarkstore.com/reports/Germany-In-Vitro-Diagnostics-Investment-Opportunities-Analysis-and-Forecasts-to-2015-7925.html Or email us at press@aarkstore.com or call +919272852585

Germany In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

By: Aarkstore Enterprise




welcome to Insurances.net (https://www.insurances.net) Powered by Discuz! 5.5.0   (php7, mysql8 recode on 2018)